Drug intelligence / Profile preview

1,2,3,4,6-penta-O-galloyl-beta-D-glucose

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) is a naturally occurring polyphenolic compound and a major gallotannin found in various medicinal plants, including *Paeonia lactiflora* (peony root), *Curcuma longa* (turmeric), and *Mangifera indica* (mango). As a research compound, it has demonstrated a wide range of pharmacological activities in preclinical studies, including antioxidant, anti-inflammatory, anti-angiogenic, and anti-tumorigenic effects. Its mechanism of action is multi-targeted: it induces heme oxygenase-1 (HO-1) expression through the activation and nuclear translocation of Nrf2, inhibits the binding of vascular endothelial growth factor (VEGF) to its receptor VEGFR2 (KDR/Flk-1), modulates the GSK3β/β-catenin signaling pathway, and stabilizes p53 by inhibiting UBE2T-mediated ubiquitination. PGG is currently being investigated for potential therapeutic applications in hepatocellular carcinoma, hepatitis B virus infection, diabetic nephropathy, and neurodegenerative diseases, although it is not yet a commercial drug.

Other names
Pentagalloylglucose1,2,3,4,6-Pentagalloylglucosebeta-Pentagalloylglucose1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranosePentagalloyl-beta-D-glucose
02

Targets

HMOX1 (Heme oxygenase 1)VEGFR2 (Vascular endothelial growth factor receptor 2)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on 1,2,3,4,6-penta-O-galloyl-beta-D-glucose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1,2,3,4,6-penta-O-galloyl-beta-D-glucose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call